Pre-order Enquiry
Request Free Sample
Global Postoperative Nausea and Vomiting (PONV) Market Size, Status and Forecast 2021-2027
SKU ID : QYR-17253069 | Publishing Date : 25-Jan-2021 | No. of pages : 95
Detailed TOC of Global Postoperative Nausea and Vomiting (PONV) Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Serotonin Antagonists
1.2.3 Steroids
1.2.4 Dopamine Antagonists
1.2.5 NK-1 Receptor Antagonists
1.2.6 Non-pharmacologic Treatment
1.2.7 Others
1.3 Market by Application
1.3.1 Global Postoperative Nausea and Vomiting (PONV) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Postoperative Nausea and Vomiting (PONV) Market Perspective (2016-2027)
2.2 Postoperative Nausea and Vomiting (PONV) Growth Trends by Regions
2.2.1 Postoperative Nausea and Vomiting (PONV) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Postoperative Nausea and Vomiting (PONV) Historic Market Share by Regions (2016-2021)
2.2.3 Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Regions (2022-2027)
2.3 Postoperative Nausea and Vomiting (PONV) Industry Dynamic
2.3.1 Postoperative Nausea and Vomiting (PONV) Market Trends
2.3.2 Postoperative Nausea and Vomiting (PONV) Market Drivers
2.3.3 Postoperative Nausea and Vomiting (PONV) Market Challenges
2.3.4 Postoperative Nausea and Vomiting (PONV) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue
3.1.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue (2016-2021)
3.1.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Players (2016-2021)
3.2 Global Postoperative Nausea and Vomiting (PONV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Postoperative Nausea and Vomiting (PONV) Revenue
3.4 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio
3.4.1 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Postoperative Nausea and Vomiting (PONV) Revenue in 2020
3.5 Postoperative Nausea and Vomiting (PONV) Key Players Head office and Area Served
3.6 Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service
3.7 Date of Enter into Postoperative Nausea and Vomiting (PONV) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Type
4.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Type (2016-2021)
4.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2022-2027)
5 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Application
5.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Application (2016-2021)
5.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027)
6.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Type
6.2.1 North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021)
6.2.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027)
6.2.3 North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2027)
6.3 North America Postoperative Nausea and Vomiting (PONV) Market Size by Application
6.3.1 North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021)
6.3.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027)
6.3.3 North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2027)
6.4 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country
6.4.1 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021)
6.4.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027)
7.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type
7.2.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021)
7.2.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027)
7.2.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2027)
7.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application
7.3.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021)
7.3.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027)
7.3.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2027)
7.4 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country
7.4.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021)
7.4.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027)
8.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type
8.2.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2027)
8.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application
8.3.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2027)
8.4 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region
8.4.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027)
9.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type
9.2.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021)
9.2.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027)
9.2.3 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2027)
9.3 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application
9.3.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021)
9.3.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027)
9.3.3 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2027)
9.4 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country
9.4.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021)
9.4.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size (2016-2027)
10.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type
10.2.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2027)
10.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application
10.3.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2027)
10.4 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country
10.4.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Acacia Pharma
11.1.1 Acacia Pharma Company Details
11.1.2 Acacia Pharma Business Overview
11.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Introduction
11.1.4 Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.1.5 Acacia Pharma Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Introduction
11.3.4 Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Ani Pharmaceuticals
11.4.1 Ani Pharmaceuticals Company Details
11.4.2 Ani Pharmaceuticals Business Overview
11.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Introduction
11.4.4 Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.4.5 Ani Pharmaceuticals Recent Development
11.5 Camurus
11.5.1 Camurus Company Details
11.5.2 Camurus Business Overview
11.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Introduction
11.5.4 Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.5.5 Camurus Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Introduction
11.6.4 Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.6.5 Sanofi Recent Development
11.7 Helsinn Holding
11.7.1 Helsinn Holding Company Details
11.7.2 Helsinn Holding Business Overview
11.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Introduction
11.7.4 Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.7.5 Helsinn Holding Recent Development
11.8 Eisai
11.8.1 Eisai Company Details
11.8.2 Eisai Business Overview
11.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Introduction
11.8.4 Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.8.5 Eisai Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Postoperative Nausea and Vomiting (PONV) Introduction
11.9.4 Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.9.5 Merck Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Introduction
11.10.4 GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
11.10.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Postoperative Nausea and Vomiting (PONV) Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Serotonin Antagonists
Table 3. Key Players of Steroids
Table 4. Key Players of Dopamine Antagonists
Table 5. Key Players of NK-1 Receptor Antagonists
Table 6. Key Players of Non-pharmacologic Treatment
Table 7. Key Players of Others
Table 8. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Postoperative Nausea and Vomiting (PONV) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Postoperative Nausea and Vomiting (PONV) Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Postoperative Nausea and Vomiting (PONV) Market Share by Regions (2016-2021)
Table 12. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Postoperative Nausea and Vomiting (PONV) Market Share by Regions (2022-2027)
Table 14. Postoperative Nausea and Vomiting (PONV) Market Trends
Table 15. Postoperative Nausea and Vomiting (PONV) Market Drivers
Table 16. Postoperative Nausea and Vomiting (PONV) Market Challenges
Table 17. Postoperative Nausea and Vomiting (PONV) Market Restraints
Table 18. Global Postoperative Nausea and Vomiting (PONV) Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Postoperative Nausea and Vomiting (PONV) Market Share by Players (2016-2021)
Table 20. Global Top Postoperative Nausea and Vomiting (PONV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2020)
Table 21. Ranking of Global Top Postoperative Nausea and Vomiting (PONV) Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service
Table 25. Date of Enter into Postoperative Nausea and Vomiting (PONV) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2016-2021)
Table 29. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Postoperative Nausea and Vomiting (PONV) Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2016-2021)
Table 33. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2022-2027) & (US$ Million)
Table 65. Acacia Pharma Company Details
Table 66. Acacia Pharma Business Overview
Table 67. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product
Table 68. Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 69. Acacia Pharma Recent Development
Table 70. F. Hoffmann-La Roche Company Details
Table 71. F. Hoffmann-La Roche Business Overview
Table 72. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product
Table 73. F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 74. F. Hoffmann-La Roche Recent Development
Table 75. Novartis Company Details
Table 76. Novartis Business Overview
Table 77. Novartis Postoperative Nausea and Vomiting (PONV) Product
Table 78. Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 79. Novartis Recent Development
Table 80. Ani Pharmaceuticals Company Details
Table 81. Ani Pharmaceuticals Business Overview
Table 82. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product
Table 83. Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 84. Ani Pharmaceuticals Recent Development
Table 85. Camurus Company Details
Table 86. Camurus Business Overview
Table 87. Camurus Postoperative Nausea and Vomiting (PONV) Product
Table 88. Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 89. Camurus Recent Development
Table 90. Sanofi Company Details
Table 91. Sanofi Business Overview
Table 92. Sanofi Postoperative Nausea and Vomiting (PONV) Product
Table 93. Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 94. Sanofi Recent Development
Table 95. Helsinn Holding Company Details
Table 96. Helsinn Holding Business Overview
Table 97. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product
Table 98. Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 99. Helsinn Holding Recent Development
Table 100. Eisai Company Details
Table 101. Eisai Business Overview
Table 102. Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 103. Eisai Recent Development
Table 104. Merck Company Details
Table 105. Merck Business Overview
Table 106. Merck Postoperative Nausea and Vomiting (PONV) Product
Table 107. Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 108. Merck Recent Development
Table 109. GlaxoSmithKline Company Details
Table 110. GlaxoSmithKline Business Overview
Table 111. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product
Table 112. GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2016-2021) & (US$ Million)
Table 113. GlaxoSmithKline Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Postoperative Nausea and Vomiting (PONV) Market Share by Type: 2020 VS 2027
Figure 2. Serotonin Antagonists Features
Figure 3. Steroids Features
Figure 4. Dopamine Antagonists Features
Figure 5. NK-1 Receptor Antagonists Features
Figure 6. Non-pharmacologic Treatment Features
Figure 7. Others Features
Figure 8. Global Postoperative Nausea and Vomiting (PONV) Market Share by Application: 2020 VS 2027
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Postoperative Nausea and Vomiting (PONV) Report Years Considered
Figure 13. Global Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Postoperative Nausea and Vomiting (PONV) Market Share by Regions: 2020 VS 2027
Figure 16. Global Postoperative Nausea and Vomiting (PONV) Market Share by Regions (2022-2027)
Figure 17. Global Postoperative Nausea and Vomiting (PONV) Market Share by Players in 2020
Figure 18. Global Top Postoperative Nausea and Vomiting (PONV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue in 2020
Figure 20. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2016-2021)
Figure 21. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2022-2027)
Figure 22. North America Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Postoperative Nausea and Vomiting (PONV) Market Share by Type (2016-2027)
Figure 24. North America Postoperative Nausea and Vomiting (PONV) Market Share by Application (2016-2027)
Figure 25. North America Postoperative Nausea and Vomiting (PONV) Market Share by Country (2016-2027)
Figure 26. United States Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Postoperative Nausea and Vomiting (PONV) Market Share by Type (2016-2027)
Figure 30. Europe Postoperative Nausea and Vomiting (PONV) Market Share by Application (2016-2027)
Figure 31. Europe Postoperative Nausea and Vomiting (PONV) Market Share by Country (2016-2027)
Figure 32. Germany Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Share by Region (2016-2027)
Figure 42. China Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Postoperative Nausea and Vomiting (PONV) Market Share by Type (2016-2027)
Figure 50. Latin America Postoperative Nausea and Vomiting (PONV) Market Share by Application (2016-2027)
Figure 51. Latin America Postoperative Nausea and Vomiting (PONV) Market Share by Country (2016-2027)
Figure 52. Mexico Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Share by Country (2016-2027)
Figure 58. Turkey Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Acacia Pharma Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 62. F. Hoffmann-La Roche Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 64. Ani Pharmaceuticals Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 65. Camurus Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 67. Helsinn Holding Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 68. Eisai Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 69. Merck Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 70. GlaxoSmithKline Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Keyplayers in Global Postoperative Nausea and Vomiting (PONV) Market Size, Status and Forecast 2021-2027
Acacia PharmaF. Hoffmann-La Roche
Novartis
Ani Pharmaceuticals
Camurus
Sanofi
Helsinn Holding
Eisai
Merck
GlaxoSmithKline
Request Sample
Request Discount
